CVS HEALTH Corp
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 2, 2025), CVS HEALTH Corp reported 3 stock positions worth $172.7 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 99.7% of the portfolio, followed by Prudential Financial (PRU, 0.2%) and Health Catalyst (HCAT, 0.1%). Compared with Q4 2024, it reduced 1. The biggest sale was SS SPDR S&P 500 ETF Trust-US (SPY, shares −23%).
- Most Recent 13F
- Q2 2026
- Location
- WOONSOCKET, RI
- CIK
- 0000064803
- Portfolio Value
- $172.7M (Q1 2025)
- SEC Filing
- 0000947871-25-000445 ↗ filed May 2, 2025
Holdings Value
Holdings 3 stocks · $172.7M
Portfolio Sells Q4 2024 → Q1 2025
| SPY SS SPDR S&P 500 ETF Trust-US | Reduce -22.6% | 99.74% | −0.02 |
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 21 | $225.2M | IGSB, IGIB, IEI, SHY, USHY |
| Q1 2026 | 33 | $212.3M | SPY, IEI, SHY, IGSB, AGG |
| Q4 2025 | 9 | $135.3M | SPY, USHY, IGIB, JAAA, IGSB |
| Q3 2025 | 3 | $102.9M | SPY, PRU, HCAT |
| Q2 2025 | 3 | $190.6M | SPY, PRU, HCAT |
| Q1 2025 | 3 | $172.7M | SPY, PRU, HCAT |
| Q4 2024 | 3 | $233.7M | SPY, PRU, HCAT |
| Q3 2024 | 5 | $230.2M | SPY, VYM, HDV, PRU, HCAT |
| Q2 2024 | 5 | $216.8M | SPY, VYM, HDV, PRU, HCAT |
| Q1 2024 | 5 | $211.7M | SPY, VYM, HDV, PRU, HCAT |